AML-119 The Impact of Post-Remission Granulocyte Colony-Stimulating Factor (G-CSF) Use (G-CSFu) in the Phase 3 Studies of Venetoclax (Ven) Combination Treatments in Patients (Pts) With Newly Diagnosed Acute Myeloid Leukemia (AML)

Autor:	DiNardo, Courtney 1, Pratz, Keith 2, Panayiotidis, Panayiotis 3, Wei, Xudong 4, Vorobyev, Vladimir 5, Illés, Àrpád 6, Kim, Inho 7, Ivanov, Vladimir 8, Ku, Grace 9, Miller, Catherine 10, Zhang, Meng 10, Tatsch, Fernando 10, Potluri, Jalaja 10, Schmidt, Xenia 10, Recher, Christian 11
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S214-S214
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect